C3.ai vs. UiPath: Which AI-Driven Tech Stock Is a Better Buy in 2026?

UiPath is favored over C3.ai as a growth investment: FY2026 revenue rose 12.7% to about $1.6 billion and net income was $282.3 million, with a 17.5% net margin and $352.2 million in free cash flow. The article says UiPath has been consistently profitable for several quarters and raised its full-year outlook, though stock-based compensation equaled 78.3% of operating cash flow. C3.ai reported FY2026 revenue down about 35.7% to $250.3 million, a $470.4 million net loss and negative $190.7 million in free cash flow; in Q1 FY2027, bookings rose 73% quarter over quarter and it turned free-cash-flow positive for the first time.

Analysis

The relative case favors PATH, but the key question is earnings quality and durability—not simply which company has reported profit. If PATH’s automation revenue can grow without relying on heavier discounting or rising stock-based compensation, operating leverage could support the multiple. Conversely, agentic workflows may reduce demand for legacy per-seat RPA even as they expand automation use; track net retention, recurring revenue growth, and SBC-adjusted cash generation before treating recent profitability as structural.

AI has greater turnaround convexity, but consumption pricing makes adoption easier at the cost of potentially less predictable revenue per customer. Bookings growth and a positive-cash-flow quarter are not yet evidence of durable conversion, particularly amid restructuring and customer concentration. The revised Baker Hughes relationship is a watch item for concentration and channel economics, not proof of broader demand deterioration.

Over the next 1–3 months, PATH guidance and evidence that growth is holding while profitability persists are the catalysts; AI needs multiple quarters of revenue stabilization and cash-flow improvement. Over 6–18 months, Microsoft, Amazon, and Salesforce can constrain standalone vendors through bundled capabilities. Snowflake integration may aid PATH distribution, but also makes differentiation and pricing power the test. A contrarian risk to the favorable PATH view: reported cash flow may overstate owner economics given SBC, while a sharp AI bookings rebound could make the bearish consensus too complacent. Verify comparable fiscal periods and metric definitions before acting on the article’s cross-company figures.

Key Decisions for Investors

• Relative-value bias: consider a modest long PATH / short AI pair, sized for AI’s potentially higher volatility. Enter in stages after checking current valuation, borrow, and latest filings; do not assume the article’s multiples remain current.
• For PATH, add only if subsequent results show sustained recurring-revenue growth and cash generation after accounting for SBC. Reassess if guidance weakens, growth decelerates materially, or SBC-adjusted cash generation deteriorates.
• Keep AI as a catalyst watch rather than a core long: require repeatable positive free cash flow, revenue stabilization, and reduced customer concentration. A single strong bookings quarter is insufficient confirmation.
• Monitor bundling and pricing pressure from MSFT, AMZN, and CRM, plus PATH customer retention and AI-related product adoption. Faster adoption without durable monetization would falsify the bullish PATH thesis.